Donayre, Josie .

HRN: 18-55-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2025
CEFUROXIME 1.5GM (VIAL)
11/28/2025
11/29/2025
IV
1.5g
Q8hours X3 Doses
Uti
Checking Initial Appropriateness 
11/28/2025
CEFUROXIME 500MG (TAB)
11/29/2025
12/06/2025
ORAL
500 Mg
Bid
Uti
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: